from breast cancer globally has been slower, increasing from about 2.5 lakhs in 1980 to 4.25 lakhs in 2010, possibly reflecting the effectiveness of early detection and advances in treatment in developed countries. According to the Indian National Cancer Registry Programme, the analysis of time trends reveals that the burden of breast cancer patients will climb to 123,634 in 2020. All the urban registries at Bangalore, Bhopal, Chennai, Delhi and Mumbai showed statistically significant increase in the incidence of breast cancer, the APC (Annual Percent Change) varying from 1.0 in Delhi to 2.7 in Bangalore. In Chennai the increase was more (APC:4.0) during the later year (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) while in Mumbai the increase was more (APC:3.1) during the earlier years (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) .
A study done by Murthy et al. (2011) shows that the Age Specific Incidence Rate for age intervals (viz.15-34, 35-44, 45-54, 55-64 and 65+ years) by period revealed an increase in the incidence of the disease in various age groups in all the registries except in Ahmedabad. Increase in MAPC% was noted in all the age-intervals in most of the registries. The MAPC% in the youngest age group of 15-34 years were 2.28, 1.42, and 5.89 while for the oldest age interval of 65+ years, it ranged from 0.97% to 2.35% in Chennai, Mumbai and Nagpur respectively. In Bangalore and Delhi, except in the first and the first two age intervals, increases were noted in other age groups. Henderson et al. (1979) also reveals that breast cancer incidence has a distinctive age-specific curve. The rapid rate of increase before the menopause (ages 40-50) slows down after that, probably owing to diminishing levels of circulating oestrogens in low-incidence countries, the slope of the curve after the menopause may be flat, or even negative. This is a consequence of increasing risks of occurrence in consecutive generations of women rather than a real decline in risk with age. Farley et al. (2000) shows variation in age incidence rates in India. It suggests that the disease peaks at a younger age (e.g. 40-50 years) than in Western countries and as a result, the majority of new diagnosis occur in pre-menopausal women.
Farley, (2001) points out that the current agestandardized rate is 19.1 per 100000 per annum, but, in contrast to what is observed in developed countries, the incidence rate peaks below age 50. Jussawalla et al. (1981) , in a study in greater Bombay shows the distribution according to histological types of breast cancer in India. It is characterized by a high frequency of infiltrating duct carcinoma. Medullary, lobular, and squamous cell carcinoma were typical histological varieties of the older age groups, whereas ductal carcinoma was encountered mostly in premenopausal women Chintamani et al. (2005) , in another study shows various morphological variants and patterns of Breast cancer. The histomorphological types seen among 569 female breast cancers , 502 cases (88.2%) with histology of IDC was found to be the most common type and followed in decreasing order by infiltrating lobular carcinoma in 21 cases (3.7%); colloid carcinoma in 6 cases (1.1%), ductal carcinoma-in-situ in 6 cases (1.1%), metaplastic type in 5 cases (0.9%), schirrous carcinoma in 5 cases (0.9%), apocrine type in 4 cases (0.7%) and the rest 20 cases (3.5%) with other types of carcinoma. Albrektse et al. (2010) in a study showed ductal tumors, the most common histological type accounted for 81.4% of all cases, followed by lobular tumors (6.3%) and unspecified carcinomas (5.5%). Other subtypes accounted for 0.4%-1.5% of the cases each. For all histological types, the proportions differed significantly by age at diagnoses
The Madras Metropolitan Tumour Registry (MMTR), underwent a survival study by Gazalakshmi et al. (1997) of 1747 cases of invasive female breast cancer registered in MMTR during 1982-89. The mean follow-up time was 43 months. The overall Kaplan-Meier observed survival rates at 1, 3 and 5 years were 80%, 58% and 48% respectively; the corresponding figures for relative survival were 81%, 61% and 51% 
Materials and Methods

Results
The Table 1 The Table 2 shows that of total no. of breast cancers, majority were in the 40-49 year old age group in 1997 -2004, varying from 29.69% in 1997 to 32.04% in 2002 and 27.85% in 2004 . The next most commonly affected age group was 50-59 year age group, varying from 22.8% in 1997 to 24.6% in 2002 to 24.4% in 2004. According to distribution of breast cancer patients, according to treatment (Table 3) , the main modality of treatment was surgery and radiotherapy followed by combined treatment of surgery, chemotherapy and radiotherapy followed by combined treatment of surgery and chemotherapy. Majority, 23.8% underwent surgery in In this eight year study (Table 5) A study done by Ahmed et al. (2011) shows breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in females worldwide, accounts for 23% (1.38 millions) of total cancer cases and 14% (458,499) of total cancer deaths in 200814( (Parkin et al., in a study in 2000 shows that breast cancer, although it is the second most common cancer overall (1.05 million new cases) ranks much less highly (5 th ) as a cause of death because of the relatively favourable prognosis (ratio of mortality:incidence = 0.4). In terms of prevalence, the most common cancer is breast (3.9 million breast cancer cases. The ratio between prevalence and incidence is an indicator of prognosis. This explains why breast cancer appears as the most prevalent cancer in the world, despite there being fewer new cases than for lung cancer, for which the outlook is considerably poorer. revealed that breast cancer resulted in an estimated 189,000 deaths in developed countries and 184,000 deaths in developing countries, accounting for16 and 12 percent, respectively, of all cancer deaths in woman.
A study done by Forbes, (1997) points out that over the past several decades, the risk of breast cancer in developed countries has increased by one to two percent annually. In our study in eight year time period, major patients were in the 40-49 year old age group in [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] 29 .69% in 1997 to 32.04% in 2002 and finally to 27.85% in 2004 and the next most commonly affected age group was 50-59 year age group which varies from 22.80% in 1997 to 24.60% in 2002 and ultimately to 24.43% in 2004 In a study in Netherlands by Louwman et al. (1975 Louwman et al. ( : 2004 reveals that incidence for patients aged below 40 and 40-49 has increased by 2.1% and 2.4% annually, since 1995 (p = 0.08 and p = 0.001, respectively). Mortality decreased in all age groups, but most markedly among women aged 50-69 (-1.5% yearly since 1985, p = 0.14).
Age is the single most important risk factor for breast cancer. Forbes, (1997) shows that compared with women in their twenties, women are 10 times as likely to develop breast cancer in their thirties, 40 times as likely in their forties, 60 times as likely in their fifties, and 90 times as likely after age 60. Breast cancer incidence has a distinctive age-specific curve.
The observation by Henderson BE et al in 1988 reveals that the rapid rate of increase before the menopause (ages 40-50) slows down after that, probably owing to diminishing levels of circulating oestrogens.In our study, according to treatment modality, the main modality of treatment was surgery and radiotherapy.It was followed by combined treatment of surgery, chemotherapy and radiotherapy and by combined treatment of surgery and chemotherapy. Majority, 23.77% underwent surgery in 1997,rising to 27.65% in 1998 then declining to 22. In a study, of the 173 confirmed cases of breast cancer, 65 (37.6%) declined any form of treatment. Among the remaining 108 patients, 57(52.8%) accepted only a single treatment modality, while 51 (47.2%)accepted two or more treatment modalities.
In a study in Eastern Nigeria by Stanley et al. (???? ) , a total of 140 patients were offered therapeutic surgery at some point in their management; 71 (50.7%) accepted some form of mastectomy and 2 requested and received wide local excision. 49surgery patients (67%) had chemotherapy and 16 (22%) had chemotherapy plus radiotherapy. Only 23 patients received radiotherapy; of these, 16 received radiotherapy in conjunction with surgery while 7 received radiotherapy for locally unresectable lesions. Of the four functional radiotherapy units in Nigeria, the nearest was 600 km from the Breast Clinic on poorly maintained roads. For those patients accepting treatment, the most common reasons for discontinuation of treatment were cost of the treatment,no bed space in the hospital and lack of a relative to care for them. Peto et al. (2000) in a study in UK and USA shows Improved treatment of women who develop breast cancer also is essential to reducing breast cancer mortality. Along with mammography screening, advances in the treatment of breast cancer have fueled a sharp drop in breast cancer mortality over the past 15 years in the United States and the United Kingdom Jussawalla et al. (1981) , in a study in greater Bombay in 1981 points out the distribution of breast cancer according to histologic types of breast cancer in India is characterized by a high frequency of infiltrating duct carcinoma. Medullary, lobular, and squamous cell carcinoma were typical histological varieties of the older age groups, whereas ductal carcinoma was encountered mostly in Nandakumar et al. (1995) reflects the aggressiveness of the disease, the effectiveness of treatment and host factors such as age. There have been very few reports on survival from cancer in India, mainly because of poor patient follow-up and inadequate system of registration of death. Dhar et al. (2008) in a study in shows the numerous difficulties in the conduct of a population-based survival study in the context of developing countries, including India. Loss to follow-up is a typical problem encountered, causing biased estimates. In view of this difficulty with the classical approach, the objective of this study was to propose an indirect methodology for the study of survival. The proposed methodology is based on life table techniques and uses current data on incidence and mortality from the disease.
In this eight year study in CNCI, status of patients on last day of the respective year was assessed. The percentage death gradually increased to 56.45% in 2001 and again fell to 55.01% in 2001 and gradually came down to 47.4% in 2004.There was overall rise in percentage of alive patients. Also with every passing year, percentage of death gradually decreased. Better pattern of care(diagnosis and treatment) was reflected in this picture. However, lost to follow up which also implies non compliance to treatment was basically unchanged.
Despite much research, breast cancer persists as a major health burden. The observed improvement in survival of breast cancer patients during the last three decades is impressive. It is likely that the descriptive epidemiology of breast cancer will continue to provide insights into the etiology of the disease and will allude to the role of primary prevention, early diagnosis and treatment. There have been few reports on survival from cancer in India, mainly because of poor patient followup and inadequate system of registration of death. The implementation of cancer as a Notifiable disease in India is the only solution to assess the proper burden of breast cancer and can be helpful to conduct survival studies. The combination of increasing incidence and improved survival rates implies that the number of prevalent cases will continue to increase considerably in the next 10 years. The survival studies can pinpoint the lacunae in treatment modalities and can guide us to do basic and translational research so the preventive strategies cmulated.
